Logo

ATPC

Agape ATP Corporation

ATPC

Agape ATP Corporation • NASDAQ
$1.29 ▼ -1.15% (-0.01)
Market Cap $64.53 M
52w High $2.93
52w Low $0.90
Dividend Yield 0%
P/E -5.16
Volume 63.87K
Outstanding Shares 50.03M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $370.593K ▼ $840.424K ▼ $-592.978K ▲ -160.008% ▼ $-0.01 ▲ $-518.103K ▲
Q2-2025 $465.499K ▲ $845.901K ▼ $-617.078K ▲ -132.563% ▲ $-0.012 ▲ $-592.725K ▲
Q1-2025 $289.037K ▼ $876.69K ▼ $-698.949K ▲ -241.82% ▼ $-0.18 ▲ $-669.379K ▲
Q4-2024 $359.776K ▲ $1.026M ▲ $-808.439K ▼ -224.706% ▼ $-0.2 ▼ $-779.622K ▼
Q3-2024 $331.289K $732.295K $-509.628K -153.832% $-0.13 $-484.137K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $133.714K ▼ $24.389M ▼ $1.589M ▲ $22.833M ▼
Q2-2025 $215.973K ▼ $24.721M ▼ $1.315M ▲ $23.431M ▼
Q1-2025 $578.794K ▼ $25.185M ▲ $1.153M ▼ $24.05M ▲
Q4-2024 $2.04M ▼ $3.24M ▼ $1.311M ▲ $1.933M ▼
Q3-2024 $2.719M $3.964M $1.2M $2.748M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-595.37K ▲ $-256.742K ▲ $-7 ▲ $181.331K ▲ $-82.259K ▲ $-256.749K ▲
Q2-2025 $-623.246K ▲ $-494.458K ▲ $-11 ▲ $121.02K ▼ $-362.821K ▲ $-494.469K ▲
Q1-2025 $-712.919K ▲ $-1.454M ▼ $-23.001M ▼ $22.995M ▲ $-1.461M ▼ $-1.455M ▼
Q4-2024 $-826.595K ▼ $-645.335K ▼ $-1.439K ▲ $-5.165K ▼ $-678.79K ▼ $-646.775K ▼
Q3-2024 $-524.039K $-424.88K $-45.044K $-3.844K $-441.951K $-470.035K

Revenue by Products

Product Q1-2025Q2-2025Q3-2025
Energized Mineral Concentrate
Energized Mineral Concentrate
 $0 ▲$0 ▲$0 ▲
Health and Wellness Services
Health and Wellness Services
 $0 ▲$0 ▲$0 ▲
Product
Product
 $0 ▲$0 ▲$0 ▲
Product Health Therapies
Product Health Therapies
 $0 ▲$0 ▲$0 ▲
Ionized Cal Mag
Ionized Cal Mag
 $0 ▲$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement ATPC looks like a very early-stage, pre-revenue company from the reported figures. Over the last several years, it shows essentially no sales and no gross profit, so the business model has not yet translated into measurable operating income. Earnings per share have moved further into negative territory, suggesting expenses and one-off listing or growth-related costs are rising faster than any early commercial traction. In plain terms: this is a story and strategy phase, not an earnings and revenue phase, and the path to meaningful, recurring revenue is still unproven in the historical numbers provided.

Balance Sheet

Balance Sheet The balance sheet appears extremely light, with only a small base of assets and equity and no reported debt. That means there is no obvious leverage risk, but also very little asset backing or buffer if things go wrong. The lack of reported cash and the tiny scale of assets suggest ATPC is still building its financial foundation and likely depends heavily on external funding rather than internally generated resources. Overall, the balance sheet looks more like that of a newly formed, development-stage company than a mature packaged foods or energy business.

Cash Flow

Cash Flow Reported cash flows from operations, investing, and free cash flow are essentially flat and negligible, which is consistent with a pre-revenue entity. There is no evidence yet of the business generating its own cash to fund growth. This implies that expansion into wellness, green energy, and oil and gas will likely rely on capital raises or partner financing rather than internal cash generation for the foreseeable future. The key uncertainty is how long external funding can support operations before meaningful cash inflows materialize.

Competitive Edge

Competitive Edge ATPC’s competitive idea is to link wellness, senior care, and energy solutions into a broad ecosystem rather than compete on a single product. In wellness, the mix of anti-aging supplements, therapies, and senior living is differentiated locally but operates in a very crowded and credibility-sensitive market. In energy, the company is trying to gain a foothold via partnerships in EV charging, solar, and large oil and gas trading deals, which could create scale quickly but also place it against established global players. The overall competitive position is conceptually interesting but still largely untested in the marketplace, with execution and partner reliability as major swing factors.

Innovation and R&D

Innovation and R&D The main innovation story centers on its integrated wellness ecosystem and the ATP2 supplement, which is marketed as using a special hydrogen acetate technology combined with a rich mix of nutrients. However, public information on patents, independent scientific validation, and clinical evidence is limited, leaving questions about how defensible and differentiated this technology really is. On the energy side, ATPC leans more on strategic alliances and acquisitions than on in-house R&D, using partners for EV charging infrastructure and advanced solar panels. Future value creation will likely hinge on converting these concepts and collaborations into proven, scalable offerings with clear intellectual property or structural advantages, rather than on marketing claims alone.

Summary

ATPC is essentially a very early-stage, multi-concept company: it is listed, has ambitious plans in wellness and energy, but shows almost no historical revenue, profits, or cash generation. Financially, it behaves more like a development vehicle than an operating packaged foods or energy firm, with a thin balance sheet and dependence on external capital. Strategically, it is trying to build a holistic wellness platform while simultaneously pushing into green energy and oil and gas trading, which creates both diversification and complexity. The big questions are whether its wellness technologies can be scientifically and commercially validated, whether the energy partnerships can be executed at scale, and how quickly the company can move from vision and agreements to tangible, recurring financial results.